Toll Biotech Co.Ltd.(Beijing)
拓领博泰
Toll Biotech Co.Ltd.(Beijing)
Biotech/Healthcare
Founded in April 2020, Tuoling Botai focuses on developing novel drugs for autoimmune diseases. The company holds multiple patents for small molecules that regulate innate immunity, with coverage across the world's major drug-development markets.
Latest round: Series B Extension (2026)
Source: ChinaBulls — chinabulls.com
Last updated 2026-04-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.